Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström(Uppsala University), Patricio López‐Jaramillo(Universidad De Santander), Deepak L. Bhatt(Mount Sinai Hospital), Rafael Díaz(Estudios Clínicos Latinoamérica), Nikolaus Marx(RWTH Aachen University), Jay M. Edelberg, Nicolas Danchin(Assistance Publique – Hôpitaux de Paris), Peter Sinnaeve(Brigham and Women's Hospital), Robert Pordy(Inserm), Shaun G. Goodman(University of Toronto), Vera Bittner(University of Alabama at Birmingham), Jennifer McGinniss(Regeneron (United States)), Robert A. Harrington(Clinical Research Institute), Andreas M. Zeiher(Goethe University Frankfurt), Harvey D. White(University of Auckland), Juan Carlos Prieto, Gregory G. Schwartz(University of Colorado Denver), Renato D. Lópes(Duke University), Michael Szarek(St. Michael's Hospital), Heinz Drexel(ESCP Business School), Evangelos Liberopoulos(National and Kapodistrian University of Athens), Garen Manvelian(Regeneron (United States)), Pierluigi Tricoci(Duke University), Mirza Dilić(Duke University), Angèle Moryusef(Inserm), William J. Sasiela(Inserm), Corinne Hanotin, Guillaume Lecorps(Sanofi (United States)), Matthew T. Roe(Inserm), Jean‐François Tamby(Medical University of South Carolina), Philip E Aylward, Huo Yong, Michel Scemama(Sanofi (France)), Kenneth W. Mahaffey, Shaun G. Goodman(St. Michael's Hospital), Philippe Gabríel Steg(Mount Sinai Hospital), Nina N Gotcheva, J. Wouter Jukema(Leiden University Medical Center)
Circulation
August 29, 2022
Cited by 123


Related Papers